Delayed-Action Preparations

"Delayed-Action Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Dosage forms of a drug that act over a period of time by controlled-release processes or technology.

Descriptor ID	D003692
MeSH Number(s)	D26.255.210 E02.319.300.253
Concept/Terms	Delayed-Action Preparations Delayed-Action Preparations Delayed Action Preparations Delayed-Action Preparation Controlled-Release Preparations Controlled-Release Preparations Controlled Release Preparations Controlled-Release Preparation Controlled-Release Formulations Controlled Release Formulations Controlled-Release Formulation Sustained-Release Preparations Sustained-Release Preparations Sustained-Release Preparation Extended Release Preparations Extended Release Preparation Slow Release Formulation Sustained Release Formulations Sustained Release Formulation Extended Release Formulations Extended Release Formulation Timed-Release Preparations Timed-Release Preparations Timed Release Preparations Timed-Release Preparation Depot Preparations Depot Preparations Depot Preparation Prolonged-Action Preparations Prolonged-Action Preparations Prolonged-Action Preparation

Below are MeSH descriptors whose meaning is more general than "Delayed-Action Preparations".

Chemicals and Drugs [D]
Pharmaceutical Preparations [D26]
Dosage Forms [D26.255]
Delayed-Action Preparations [D26.255.210]
Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Delivery Systems [E02.319.300]
Delayed-Action Preparations [E02.319.300.253]

Below are MeSH descriptors whose meaning is related to "Delayed-Action Preparations".

Below are MeSH descriptors whose meaning is more specific than "Delayed-Action Preparations".

Delayed-Action Preparations
Drug Implants
Tablets, Enteric-Coated

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Delayed-Action Preparations" by people in this website by year, and whether "Delayed-Action Preparations" was a major or minor topic of these publications.

Bar chart showing 69 publications over 20 distinct years, with a maximum of 9 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1999	0	1	1
2002	0	1	1
2004	0	2	2
2005	1	1	2
2006	0	2	2
2007	1	2	3
2008	0	4	4
2009	0	3	3
2010	0	3	3
2012	0	2	2
2013	0	3	3
2014	0	6	6
2015	0	2	2
2016	2	3	5
2017	1	8	9
2018	3	4	7
2019	2	3	5
2020	2	2	4
2021	1	3	4

Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.

Wang LS, Gopalakrishnan S, Luther DC, Rotello VM. Protein-Based Films as Antifouling and Drug-Eluting Antimicrobial Coatings for Medical Implants. ACS Appl Mater Interfaces. 2021 Oct 13; 13(40):48301-48307.

View in: PubMed
O'Sullivan DL, Byatt N, Dossett EC. Long-Acting Injectable Antipsychotic Medications in Pregnancy: A Review. J Acad Consult Liaison Psychiatry. 2022 Jan-Feb; 63(1):53-60.

View in: PubMed
Shirk SD, Ameral V, Kraus SW, Houchins J, Kelly M, Pugh K, Reilly E, Desai N. Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review. J Dual Diagn. 2021 Jul-Sep; 17(3):207-215.

View in: PubMed
Sharma M, Bhat R, Usmani Z, McClements DJ, Shukla P, Raghavendra VB, Gupta VK. Bio-Based Formulations for Sustainable Applications in Agri-Food-Pharma. Biomolecules. 2021 05 20; 11(5).

View in: PubMed
Reinstein SA, Cosgrove J, Malekshahi T, Deligiannidis KM. Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. J Clin Psychiatry. 2020 11 24; 81(6).

View in: PubMed
Pivovarova E, Min HS, Friedmann PD. Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders. Subst Abus. 2021; 42(4):618-624.

View in: PubMed
Jeffery MM, Chaisson CE, Hane C, Rumanes L, Tucker J, Hang L, McCoy R, Chen CL, Bicket MC, Hooten WM, Larochelle M, Becker WC, Kornegay C, Racoosin JA, Sanghavi D. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance. JAMA Netw Open. 2020 04 01; 3(4):e202875.

View in: PubMed
Yao M, Xie J, Du H, McClements DJ, Xiao H, Li L. Progress in microencapsulation of probiotics: A review. Compr Rev Food Sci Food Saf. 2020 03; 19(2):857-874.

View in: PubMed
Johnson ER, Taylor AR, Boothe DM, Gray-Edwards HL, Winter RL, Martin DR. Pharmacokinetics of a commercially available product and a compounded formulation of extended-release levetiracetam after oral administration of a single dose in cats. Am J Vet Res. 2019 Oct; 80(10):950-956.

View in: PubMed
Yant SR, Mulato A, Hansen D, Tse WC, Niedziela-Majka A, Zhang JR, Stepan GJ, Jin D, Wong MH, Perreira JM, Singer E, Papalia GA, Hu EY, Zheng J, Lu B, Schroeder SD, Chou K, Ahmadyar S, Liclican A, Yu H, Novikov N, Paoli E, Gonik D, Ram RR, Hung M, McDougall WM, Brass AL, Sundquist WI, Cihlar T, Link JO. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. Nat Med. 2019 09; 25(9):1377-1384.

View in: PubMed

People

Explore

Similar Concepts

Top Journals